Plain-English translation of NCT06839105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new cancer medication called to see if it is safe and works well for people with advanced cancers that have spread or cannot be surgically removed. The researchers want to understand how this medication affects the body and whether it helps when given alone or combined with other standard cancer treatments like chemotherapy.
Many patients with advanced cancers have limited treatment options because their cancer has stopped responding to current standard therapies or they cannot tolerate them. This trial explores whether this new medication could offer hope to these patients, either as a new option by itself or as a way to improve existing treatments.
You likely qualify if…
You likely don't qualify if…
Participants will visit the clinic regularly to receive either as a single medication or combined with standard chemotherapy or other cancer drugs, depending on which group they join. You will have blood tests, imaging scans, and physical exams to check how the medication is working and whether you experience any side effects. The study involves close monitoring, but the exact schedule and duration will depend on your specific treatment group and how well you tolerate the medication.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China